Related Experiment Video

Updated: Jun 21, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Transforming growth factor-beta and mutant p53 conspire to induce metastasis by antagonizing p63: a (ternary) complex

Jean-Christophe Marine1, Geert Berx

  • 1Laboratory for Molecular Cancer Biology, VIB-UGent, Technologiepark, 927, B-9052 Ghent, Belgium. chris.marine@dmbr.ugent.be

Breast Cancer Research : BCR
|August 12, 2009
PubMed

Insights

Transforming growth factor-beta (TGFbeta) and oncogenic Ras collaborate to inhibit p63

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis Research

Background:

  • The mechanisms driving tumor metastasis are not fully understood.
  • Transforming growth factor-beta (TGFbeta) and oncogenic Ras signaling pathways are implicated in cancer progression.
  • The role of p63 in preventing metastasis needs further elucidation.

Purpose of the Study:

  • To investigate the intricate mechanism by which TGFbeta and oncogenic Ras cooperate to suppress the metastasis-protective function of p63.
  • To identify key molecular players and pathways involved in p63 inhibition during tumor metastasis.
  • To explore the potential of p63 downstream targets as prognostic markers for breast cancer metastasis.

Main Methods:

  • Investigated the interaction between TGFbeta, oncogenic Ras, p63, mutant p53, and Smads.
  • Utilized molecular biology techniques to study the formation of a p63-Smads-mutant p53 ternary complex.
  • Analyzed the expression of p63 downstream targets in breast cancer samples.

Main Results:

  • Discovered a novel mechanism where TGFbeta and oncogenic Ras antagonize p63's metastasis-protective function.
  • Demonstrated that p63 inhibition requires the concerted action of Ras-activated mutant p53 and TGFbeta-induced Smads.
  • Identified a ternary complex formation involving p63, Smads, and mutant p53.
  • Found that two key downstream targets of p63 are sufficient as a prognostic tool for breast cancer metastasis.

Conclusions:

  • The study reveals a new molecular mechanism regulating cancer metastasis.
  • The findings highlight a critical interplay between TGFbeta, Ras, p63, mutant p53, and Smads in controlling metastatic potential.
  • The identified p63 downstream targets offer a promising prognostic tool for breast cancer.
  • The elucidated mechanism suggests novel therapeutic strategies for combating metastasis.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...